SPEC — SpectraCure AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK24.82m
- SEK26.10m
- SEK0.87m
Brief: SpectraCure Receives Research Contribution From The EU
Brief: SpectraCure Q3 Loss After Tax Widens To SEK 3.1 Mln
Brief: SpectraCure To Move Its Stock Trading To First North Premier Growth Market
Brief: SpectraCure Q2 Loss After Tax At SEK 4.1 Million
Brief: Spectracure Reports Positive Results From Co's Clinical Phase 1 Study
Brief: SpectraCure Gets Additional Research Grant From Vinnova
Brief: SpectraCure Q1 Operating Loss At SEK 2.8 Million
Brief: SpectraCure Announces Preliminary Results From Co's Prostate Treatment
Brief: SpectraCure Applies For New Patent
Brief: Spectracure Extends Contract With Hospital In London
Brief: Spectracure AB (Publ) Q4 Operating Loss Sek 3.2 Million
Brief: SpectraCure Presents Clinical Study Results For Patient 9 And 10
Brief: Spectracure Gets Grant Of SEK 5 Mln From Eurostars Program
Brief: Spectracure AB (Publ) Approved For Listing On Nasdaq First North Stockholm
Brief: SpectraCure: New Share Issue Of SEK 52.4 Mln Subscribed To About 123 Pct
Brief: SpectraCure Carries Out Rights Issue Of About SEK 52.4 Mln Before Issue Costs
Brief: SpectraCure Q2 Net Loss Widens To SEK 4.0 Million
Brief: SpectraCure Signs Agreement With University Of Pennsylvania Hospital
Brief: Spectracure: British MHRA Approves Clinical Study